A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of TGM2 gene in pancreatic beta cells

Introduction Most of the disease-associated single nucleotide polymorphisms (SNPs) lie in non- coding regions of the human genome. Many of these variants have been predicted to impact the expression and function of long non-coding RNAs (lncRNA), but the contribution of these molecules to the development of complex diseases remains to be clarified. Methods Here, we performed a genetic association study between a SNP located in a lncRNA known as LncTGM2 and the risk of developing type 2 diabetes (T2D), and analyzed its implication in disease pathogenesis at pancreatic beta cell level. Genetic association study was performed on human samples linking the rs2076380 polymorphism with T2D and glycemic traits. The pancreatic beta cell line EndoC-bH1 was employed for functional studies based on LncTGM2 silencing and overexpression experiments. Human pancreatic islets were used for eQTL analysis. Results We have identified a genetic association between LncTGM2 and T2D risk. Functional characterization of the LncTGM2 revealed its implication in the transcriptional regulation of TGM2, coding for a transglutaminase. The T2Dassociated risk allele in LncTGM2 disrupts the secondary structure of this lncRNA, affecting its stability and the expression of TGM2 in pancreatic beta cells. Diminished LncTGM2 in human beta cells impairs glucose-stimulated insulin release. Conclusions These findings provide novel information on the molecular mechanisms by which T2D-associated SNPs in lncRNAs may contribute to disease, paving the way for the development of new therapies based on the modulation of lncRNAs.

[1]  S. Volinia,et al.  Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer , 2022, International journal of biological sciences.

[2]  P. Nathanielsz,et al.  Imprinted lncRNA Dio3os preprograms intergenerational brown fat development and obesity resistance , 2021, Nature Communications.

[3]  Qinghui Niu,et al.  Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages , 2021, International journal of biological sciences.

[4]  Hai-Feng Zhang,et al.  LncRNA H19 governs mitophagy and restores mitochondrial respiration in the heart through Pink1/Parkin signaling during obesity , 2021, Cell Death & Disease.

[5]  I. Santin,et al.  The Role of lncRNAs in Gene Expression Regulation through mRNA Stabilization , 2021, Non-coding RNA.

[6]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[7]  Leon N. Schulte,et al.  Disease-Causing Mutations and Rearrangements in Long Non-coding RNA Gene Loci , 2020, Frontiers in Genetics.

[8]  M. Kretz,et al.  From structure to function: Route to understanding lncRNA mechanism , 2020, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  P. Marchetti,et al.  The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA , 2020, Proceedings of the National Academy of Sciences.

[10]  S. Mathur,et al.  Functional Interactomes of Genes Showing Association with Type-2 Diabetes and Its Intermediate Phenotypic Traits Point towards Adipo-Centric Mechanisms in Its Pathophysiology , 2020, Biomolecules.

[11]  M. Laakso.  Biomarkers for type 2 diabetes , 2019, Molecular metabolism.

[12]  M. Antal,et al.  Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling , 2019, Cell Death and Disease.

[13]  Jiandie D. Lin,et al.  Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis , 2018, Nature Communications.

[14]  S. Volinia,et al.  A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants , 2018, Amino Acids.

[15]  P. Khavari,et al.  The functions and unique features of long intergenic non-coding RNA , 2017, Nature Reviews Molecular Cell Biology.

[16]  M. Bugliani,et al.  Palmitate-induced lipotoxicity alters acetylation of multiple proteins in clonal β cells and human pancreatic islets , 2017, Scientific Reports.

[17]  S. Kojima,et al.  Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death , 2016, Cell Death and Disease.

[18]  G. Bhagat,et al.  A long noncoding RNA associated with susceptibility to celiac disease , 2016, Science.

[19]  F. Aguilo,et al.  Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease. , 2015, Current topics in microbiology and immunology.

[20]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[21]  J. Rinn,et al.  Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution , 2015, Genome Biology.

[22]  Joaquin Dopazo,et al.  The role of the interactome in the maintenance of deleterious variability in human populations , 2014, Molecular systems biology.

[23]  Inês Barroso,et al.  Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity , 2014, Diabetes.

[24]  S. Petrini,et al.  A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic islets , 2014, Journal of proteomics.

[25]  R. Graham,et al.  Glucose Homeostasis in Mice Is Transglutaminase 2 Independent , 2013, PloS one.

[26]  Peter F. Stadler,et al.  The RNAsnp web server: predicting SNP effects on local RNA secondary structure , 2013, Nucleic Acids Res..

[27]  F. Bertuzzi,et al.  Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E , 2013, Acta Diabetologica.

[28]  Jan Gorodkin,et al.  RNAsnp: Efficient Detection of Local RNA Secondary Structure Changes Induced by SNPs , 2013, Human mutation.

[29]  Sudharsana Rao Ande,et al.  Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes. , 2012, Journal of molecular endocrinology.

[30]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[31]  J. Moreno-Navarrete,et al.  Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. , 2008, Clinical chemistry.

[32]  T. Hansen,et al.  Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early‐onset type 2 diabetes , 2007, Human mutation.

[33]  U. Boggi,et al.  The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients , 2007, Diabetologia.

[34]  S. Valdés,et al.  Population-Based Incidence of Type 2 Diabetes in Northern Spain , 2007, Diabetes Care.

[35]  G. Melino,et al.  Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.